Stuttgart (ots) - Mit den neuen Zweisitzern 718 Boxster GTS und 718 Cayman GTS baut Porsche seine ...
8,618 GPs for MedifyRemote(TM)
Stafford, England (ots/PRNewswire) - A group of 8,618 GPs have today requested MedifyRemote(TM). The GPs interest in MedifyRemote(TM) comes as a direct result of the company's first marketing initiative.
Delivery and fulfilment of this groups requirements will now commence giving strong penetration of MedifyRemote(TM) into the US$1.2B NHS mobile data communications market.
Today's result marks the start of an aggressive sales and marketing campaign launched by Medify Solutions Limited. Next step activity includes a direct email marketing campaign to UK primary caregivers, joint marketing activity with partners EMIS, further partnership activity with Vodafone UK.
Nik Ellwood, Head of Sales and Marketing for Medify Solutions Limited, comments, "This news is a significant milestone in delivering true commercial value from the potential offered by MedifyRemote(TM). We have been confident throughout in the impact our application will have on healthcare in the NHS and are now, in the very early stages of offering the product to the market, reaping the rewards of all our hard work."
Notes for interested parties:
- MedifyRemote(TM) is a subscription based application available at a cost of US$50 per month.
- MedifyRemote(TM) is the first secure mobile patient note access application to enter field use throughout the NHS.
- MedifyRemote(TM) allows the healthcare professional to access, review and update the patients' complete medical history in a single, secure session via a Microsoft Windows enabled PDA device.
- MedifyRemote is a Vodafone Certified Application
This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words "estimate," "project," "intends," "expects," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbour" provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of Medify Solutions Limited, see "Risk Factors" in the Company's Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made and the Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
ots Originaltext: Medify Solutions Ltd.
Im Internet recherchierbar: http://www.presseportal.ch